Meningococcal Disease Outbreak in Kent: Cases and Vaccination Efforts The UK Health Security Agency is actively investigating an ongoing outbreak of invasive meningococcal disease in Kent, with updates provided on a daily basis. As of 12:30pm on 22 March 2026, 20 laboratory-confirmed cases were reported, with 9 notifications still under investigation, bringing the total to 29. No new cases were confirmed since the previous update, though some previously classified cases were reclassified following further laboratory analysis. Two individuals have been confirmed to have died as a result of the outbreak, with no additional deaths reported since the last update. The outbreak has prompted a coordinated response, including the distribution of vaccines and antibiotics to at-risk populations. Eligible University of Kent students who have returned home can now access the MenB vaccination and preventative antibiotic treatment through their local GP practices. Over 4,500 vaccinations have been administered, and more than 10,500 doses of antibiotics have been distributed as of 5pm on 20 March. The MenB vaccine, which is part of the current vaccination offer, is designed to protect against the specific strain of meningococcal bacteria identified in the outbreak. Meningococcal disease, which includes meningitis and sepsis, is a rare but severe bacterial infection that can progress rapidly. Early symptoms may include a rash that does not fade when pressed, sudden high fever, severe headache, vomiting, diarrhea, joint and muscle pain, sensitivity to light, cold extremities, confusion, and extreme sleepiness. Prompt diagnosis and treatment with antibiotics are critical to improving outcomes. Young people attending university or college are particularly vulnerable due to close contact in shared living environments.#university_of_kent #uk_health_security_agency #kent #menb_vaccine #menacwy_vaccine
